- Year over Year Revenue up 27%, Gross
Profits up 58% and EBITDA up 1724% -
TORONTO and DUREN, Germany, May 4, 2023
/CNW/ - GBLT Corp. (TSXV: GBLT) ("GBLT" or the
"Company") is pleased to announce its results for the
three and twelve-month periods ended December 31st, 2022.
"We are pleased with the ongoing progress we made this past year
in scaling and focusing on our higher margin products which have
led to an all-time record turnover driven by our wide range of
healthcare and Afgaphoto products," said Dr. Thilo Senst, CEO of GBLT. "We have now
established the right foundation to continue growing our bottom
line profits this year as we scale up our product lines that are in
such high demand today. Our healthcare and our Afgaphoto products
continue to experience demand from our large retail partners, and
we are also excited to grow our solar business as we start offering
full vertical services from supplying and installing solar systems
to end users and other solar panel providers this year. Combined
with the clean energy initiatives imposed by the government and the
energy crisis caused by the Ukraine/Russia conflict, our solar energy business has
been experiencing an abundance of demand which we are working
diligently to capitalize on for our financial results in 2023. We
look forward to 2023 as we continue to grow our bottom line profits
through our highly scalable, high margin products."
Three months ended December 31,
2022, compared to the three months ended December 31, 2022
- Revenue for the three-month period ended December 31st, 2022, remained the same
at €7.96 million ($11.94 million CAD)
compared to €7.96 million ($11.94
million CAD) for the same period in 2021.
- Gross margin for the three-month period ended December 31st, 2022, was 8.6% compared
to 3.9% for the same period in 2021. The increase in gross margin
is due to GBLT's strategic focus towards scaling its higher margin
products.
- Gross profit for the three-month period ended December 31st, 2022, increased by 118%
to €0.68 million ($1.02 million CAD)
compared to €0.31 million ($0.47
million CAD) for the same period in 2021.
- Operating expenses for the three-month ended December 31st, 2022, was €1.32 million
($1.98 million CAD) compared to €0.99
million ($1.49 million CAD) in the
same period last year.
- Net income (loss) for the three-month period ended December 31st, 2022, was €(615,305)
($0.9 million CAD) compared to
€(703,239) ($1.05 million CAD) in the
same period in 2021.
- EBITDA for the three-month period ended December 31st, 2022, was €(0.50)
million ($(0.77) million CAD)
compared to €(0.62) million ($(0.93)
million CAD) for the same period in 2021
- Adjusted EBITDA for the three-month period ended December 31st, 2022, was €(0.51)
million ($0.77 million CAD) compared
to €(0.15) million ($0.21 million
CAD) for the same period in 2021.
Twelve months ended December 31,
2022, compared to the twelve months ended December 31, 2021
- Revenue for the fiscal year 2022 increased by 27.6% to €39.7
million ($59.6 million CAD) compared
to €31.1 million ($46.7 million CAD)
in 2021. The increase in revenue was due increase in customer
demand, addition of new customers and orders, and the expansion
into solar products through the acquisition of the solar panel
business (Getec), as well as more flexibility on pricing.
- Gross margin for tor the fiscal year 2022 improved to 10.0%
compared 8.0% for the same period in 2021. The increase is due to
the continued focus on pricing flexibility and higher margin
products.
- Gross profit for the fiscal year 2022 increased 58% to €4.01
million ($6.02 million CAD) compared
to €2.54 million ($3.82 million CAD)
in 2021.
- Operating expenses for the fiscal year 2022 was €3.86 million
($5.8 million CAD) compared €2.72
million ($4.08 million CAD) in
2021.
- Net Income (loss) for the fiscal year 2022 increased by 196% to
€0.17 million ($0.25 million CAD)
compared to €(0.17) million ($0.26
million CAD) in 2021.
- EBITDA for the fiscal year 2022 increased by 1724% to €0.59
million ($0.89 million CAD) compared
to €0.03 million ($0.05 million CAD)
in 2021.
- Adjusted EBITDA for the fiscal year 2022 increased by 9% to
€0.73 million ($1.10 million CAD)
compared to €0.67 million ($1.01
million CAD) in 2021.
EBITDA
|
|
Three months ended
December 31,
|
|
Fiscal
Year
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Net Income for
the
Period/Year
|
€
|
-615,302
|
€
|
-678,569
|
€
|
167,136
|
€
|
-173,775
|
Depreciation
|
|
44,284
|
|
5,634
|
|
106,231
|
|
50,207
|
Interest and financing
fees
|
|
66,614
|
|
54,746
|
|
322,904
|
|
156,124
|
EBITDA
|
|
-504,404
|
|
-618,189
|
|
596,271
|
|
32,556
|
Bad debt
expense
|
|
199,793
|
|
291,390
|
|
359,603
|
|
419,370
|
Currency exchange gain
(loss)
|
|
-205,780
|
|
65,276
|
|
-223,037
|
|
100,652
|
Share based
payments
|
|
|
|
113433
|
|
-
|
|
118,570
|
Adjusted
EBITDA
|
€
|
-510,391
|
€
|
-148,090
|
€
|
732,837
|
€
|
671,148
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EBITDA
(CAD)
|
|
Three months ended
December 31,
|
|
Fiscal
Year
|
|
|
2022
|
|
2021
|
|
2022
|
|
2021
|
Net Income for
the
Period/Year
|
$
|
-922,953
|
$
|
-1,017,854
|
$
|
250,704
|
$
|
-260,663
|
Depreciation
|
|
66,426
|
|
8,451
|
|
159,347
|
|
75,311
|
Interest and financing
fees
|
|
99,921
|
|
82,119
|
|
484,356
|
|
234,186
|
EBITDA
|
|
-756,606
|
|
-927,284
|
|
894,407
|
|
48,834
|
Bad debt
expense
|
|
299,690
|
|
437,085
|
|
539,405
|
|
629,055
|
Currency exchange gain
(loss)
|
|
-308,670
|
|
97,914
|
|
-334,556
|
|
150,978
|
Share based
payments
|
|
|
|
170149.5
|
|
|
|
177855
|
Adjusted
EBITDA
|
$
|
-765,587
|
$
|
-222,135
|
$
|
1,099,256
|
$
|
1,006,722
|
Source: Bank of Canada Exchange Rate at 2023-04-28 rate of
€1.5 per $1.00
CAD
https://www.bankofcanada.ca/rates/exchange/daily-exchange-rates/
About GBLT:
GBLT Corp., through its operating company,
GBT GmbH, designs, manufactures and supplies mobile storage, and
battery solutions. GBLT is also a leading provider of renewable
energy solutions via its solar division, participating in the
rapidly growing solar energy market. In addition, the Company
offers consumer healthcare and wellness products to some of the
largest retail chains across the globe. GBT is also an official
licensee for AGFAPHOTO mobile energy products. The Company's
branded healthcare and wellbeing products are primarily sold
throughout Europe under Dr. Senst
brand.
For more information, please visit www.gbt-international.com
and www.gbltcorp.com.
Forward-Looking
Information
Certain statements in this news release, which are not
historical in nature, constitute "forward looking statements"
within the meaning of that phrase under applicable Canadian
securities law. These statements include, but are not limited to,
statements or information concerning the Company's proposed
activities under the Agreement, the Company's ability to achieve
sales, commercial or otherwise, from its products, and the
expectations of the Company regarding funding payments due pursuant
to the Agreement. These statements reflect management's current
assumptions and expectations and by their nature are subject to
certain underlying assumptions, known and unknown risks and
uncertainties and other factors which may cause actual results,
performance or events to be materially different from those
expressed or implied by such forward looking statements. Except as
required pursuant to applicable securities laws, the Company will
not update these forward-looking statements to reflect events or
circumstances after the date hereof. More detailed information
about potential factors that could affect financial results is
included in the documents filed from time to time with the Canadian
securities regulatory authorities by the Company. Readers are
cautioned not to place undue reliance on forward looking
statements.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
SOURCE Virtus Advisory Group